Budget 2020: What does the industry want?
Last year in July, Finance Minister Nirmala Sitharaman presented the first Budget of Modi Government 2.0. Since the pharmaceutical…
Author
Rare Diseases: Awaiting renewed focus
India needs to make significant investments in R&D, policy reforms, and measures to enable affordability and accessibility of…
Proposed trade margin caps detrimental to MSMEs: SPIC to PM Modi
The SPIC's letter expressed hope that MSMEs, who are the backbone of any economy, would not be shut down for the 'sin committed by…
Online pharmacies: A rocky road ahead?
Online pharmacies have been the cause of several heated debates and discussions over the past few years. Express Pharma too has…
“We expect to analyse patient safety data more quickly and detect trends”
With the introduction of SafeTrack tool, Bayer Zydus Pharma takes a step further in enhancing pateint security. The tool allows…
CDSCO’s digital move: The way forward?
The Central Drugs Standard Control Organisation (CDSCO) is planning to develop a common software platform for all the states in…
‘Novozymes seldom competes on price’
A global leader in industrial enzymes, production firm Novozymes is looking positively at bringing in innovation. It plans to…
‘R&D continues to be the key driver for sustained growth’—Kushal Suri, Head International…
More than three decades old, research-oriented API manufacturing pharmaceutical company Morepen Laboratories has established its…
We have unlocked the potential of data in the DMTA cycle
In this progressive world, where technology is leading the future, AstraZeneca has
partnered with Nasscom for incubating tech…
‘Machine learning and Artificial intelligence is the future for automated machines’
Banagalore- based stability testing instruments provider company AMETEK India is
investing considerably for the Indian market. It…